KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Revenue: 2011-2024

Historic Revenue for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $1.9 billion.

  • Sarepta Therapeutics' Revenue rose 68.38% to $611.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.8 billion, marking a year-over-year increase of 22.84%. This contributed to the annual value of $1.9 billion for FY2024, which is 52.97% up from last year.
  • As of FY2024, Sarepta Therapeutics' Revenue stood at $1.9 billion, which was up 52.97% from $1.2 billion recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Revenue registered a high of $1.9 billion during FY2024, and its lowest value of $540.1 million during FY2020.
  • Over the past 3 years, Sarepta Therapeutics' median Revenue value was $1.2 billion (recorded in 2023), while the average stood at $1.4 billion.
  • Data for Sarepta Therapeutics' Revenue shows a peak YoY skyrocketed of 52.97% (in 2024) over the last 5 years.
  • Sarepta Therapeutics' Revenue (Yearly) stood at $540.1 million in 2020, then increased by 29.96% to $701.9 million in 2021, then soared by 32.93% to $933.0 million in 2022, then soared by 33.26% to $1.2 billion in 2023, then surged by 52.97% to $1.9 billion in 2024.